Precision Optics Corporation, Inc.

POCI ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Operating Activities
Net Income $-3.6M $-5.8M $-3.0M $-144.6K $-928.4K $-102.8K $-1.4M $-614.9K
Depreciation & Amortization $279.3K $212.4K $212.4K $210.7K $190.2K $146.8K $112.2K $38.6K
Depreciation $254.1K $187.0K — — — — — —
Amortization — — — — — — — —
Stock-Based Compensation $1.1M $1.6M $959.8K $919.0K $915.5K $733.9K $502.3K $263.3K
Net Cash from Operating Activities $-1.6M $-3.4M $-2.7M $-81.1K $-933.4K $46.6K $-592.5K $-1.0M
Investing Activities
Capital Expenditures $426.8K $227.2K $272.4K $16.8K $113.2K $75.9K $119.2K $140.0K
Business Acquisitions — — — — — $166.7K $1.4M $0
Net Cash from Investing Activities $-429.4K $-233.5K $-293.9K $-52.5K $-407.8K $-122.4K $-1.6M $-40.3K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $10.0M $5.0M $456.3K $2.5M $1.1M $-197.2K $1.0M $3.0M
Net Change in Cash — — — — — — $-1.2M $1.9M
Free Cash Flow $-2.0M $-3.6M $-3.0M $-97.9K $-1.0M $-29.4K $-711.6K $-1.2M
← Newer Page 1 of 2 Older →